By signing the UK Armed Forces Covenant, Quest Global Engineering Services has pledged to provide structured employment support for veterans, reservists, and military families. The agreement formalizes the company's efforts to integrate service members into its workforce while ensuring fair treatment across all its domestic operations.
Quest Global Engineering Services Limited has officially signed the UK Armed Forces Covenant, codifying its pledge to support veterans, reservists, and military families across its British operations. The move formalizes internal efforts to integrate service members into the company’s workforce while ensuring fair treatment for those with military backgrounds.
The new 223-bed Trebinje Hospital in the Pridvorci neighborhood has officially transformed regional healthcare, marking the largest infrastructure investment in eastern Herzegovina. Funded by the Republika Srpska government with a $75.4 million budget, the 17,500-square-meter facility aims to eliminate the need for patients to travel to distant urban centers.
London’s Olympia exhibition hall will host the debut of the HySecurity division’s CE-certified hostile vehicle mitigation systems this September. By formalizing its presence in Europe, the Nice group aims to secure critical sites like airports and data centers through high-performance barrier technology and integrated site access controls.
ProCredit group has selected the cloud-native Kondor Up platform by Teciem to overhaul its treasury infrastructure across ten banks in South-Eastern and Eastern Europe. This shift aims to replace legacy systems with a scalable, automated framework capable of managing complex risk, liquidity, and regulatory requirements across diverse international markets.
Investors who held Alibaba Group Holding Limited stock between June 26, 2025, and June 24, 2026, are being urged to join a class action lawsuit. The litigation alleges the company violated the Securities Exchange Act by issuing materially misleading statements regarding its regulatory risks and ties to state infrastructure.
With over 220,000 international buyers already pre-registered, the 140th China Import and Export Fair prepares to open its doors in Guangzhou on October 15. The milestone 70th-anniversary event shifts focus toward high-tech manufacturing, integrating advanced AI and digital infrastructure into the traditional sourcing experience for attendees from 197 countries.
Sichuan Kelun-Biotech Biopharmaceutical is set to unveil pivotal clinical results for its TROP2-targeting antibody-drug conjugate, sacituzumab tirumotecan, at the 2026 European Society for Medical Oncology Congress in Madrid. Multiple Phase III studies have been designated as Late-Breaking Abstracts, signaling significant progress in the drug's therapeutic profile.
The National University Hospital (NUH) in Singapore is rethinking diabetes management by shifting from reactive treatment to a proactive safety ecosystem. By integrating digital monitoring and nurse-led intervention protocols, the hospital’s endocrinology team aims to mitigate risks for patients across their entire journey, from hospital admission to community recovery.
Investors who purchased Capricor Therapeutics stock between December 17, 2025, and July 26, 2026, face a September 28 deadline to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding regulatory approval processes for its drug candidate, Deramiocel.
AURELIUS Midmarket portfolio companies are reshuffling their assets as EYKON confirms the sale of its water meter business to Sensus International. The move signals a strategic shift for the Swiss infrastructure firm, allowing it to double down on its core competencies in connectivity and digital utility solutions.
Investors who purchased Wix.com Ltd. shares between February 19, 2025, and May 12, 2026, face a critical deadline today to join a class action lawsuit. Schall, Brown & Schwartz LLP is seeking lead plaintiffs for the litigation, which centers on claims that the company misled shareholders regarding its AI strategy and associated costs.
Investors who held Pentair plc shares between April 28 and July 14, 2026, are being urged to join a securities class action lawsuit against the company. The litigation, led by the DJS Law Group, alleges that the firm violated federal exchange acts by masking the impact of pool product destocking.
Investors who purchased Pentair plc shares between April 28 and July 14, 2026, have until October 2 to seek lead plaintiff status in a pending class action. The litigation, led by Schall, Brown & Schwartz LLP, targets alleged misleading disclosures regarding inventory destocking that impacted the company’s financial performance.
Two AURELIUS Midmarket portfolio companies are reshuffling their assets as EYKON moves to offload its water meter business to Sensus International. The deal allows EYKON to narrow its strategic focus toward advanced connectivity and digital utility solutions, while Sensus absorbs the division to bolster its dedicated metering infrastructure.
A class action lawsuit accusing Blaize Holdings of violating federal securities laws has reached a critical juncture, with investors facing an October 5, 2026, deadline to participate. The litigation centers on claims that the company inflated its market profile by touting partnerships with entities incapable of honoring their contractual obligations.
Escalating software budgets and the pressure to integrate artificial intelligence are forcing law firms to confront a recurring fiscal disconnect. As technology spending outpaces measurable returns, many organizations are turning to modernized data architecture and automated workflows to secure their bottom line while managing heightened compliance risks.
London-based accesso Technology Group has unveiled a suite of agentic AI capabilities designed to transform how visitor attractions manage complex data. By shifting from static reporting to autonomous workflows, the platform allows operators to delegate routine analysis, forecasting, and cross-departmental monitoring to an intelligent, conversation-driven system.
Power Metallic Mines has intercepted significant copper mineralization at its Lion deposit, extending the known resource 25% deeper than previous estimates. The latest drill results from hole PML-26-125 yielded 5.7 meters of 14.00% copper equivalent at a vertical depth of approximately 800 meters, signaling potential for further expansion.
Las Vegas is betting on a post-summer surge as the annual “Vegas 5-Day Sale” officially kicks off today. Running through September 26, the campaign offers travelers deep discounts on resort stays, headline entertainment, and dining experiences across the city, aiming to convert casual interest into confirmed bookings for the coming season.
A class action lawsuit has been filed against Rackspace Technology, Inc., alleging the company misled shareholders regarding its financial health and operational shifts. The litigation focuses on statements made between May 7 and July 8, 2026, as investors seek recovery for losses sustained during a period of significant internal restructuring.
Singapore-based logistics software provider Parcel Perform is rebranding to Perform.AI, shifting its focus from simple parcel tracking to an end-to-end AI Commerce Operating System. The move reflects a new retail reality where brands must optimize their operations not just for human shoppers, but for the AI agents that influence purchase decisions.
Stockholm-based hygiene and health giant Essity will release its financial performance data for the third quarter of 2026 on October 22. The report, scheduled for publication at 07:00 CET, precedes a formal presentation by company leadership intended to detail the firm's fiscal trajectory during the current year.
Swedish precision medicine firm Beactica Therapeutics has launched IND-enabling studies for BEA-17, a first-in-class oral degrader targeting LSD1 and CoREST. This milestone moves the experimental glioblastoma treatment from preclinical proof-of-concept toward formal safety testing and regulatory filings required for human clinical trials in the United States and Europe.
Swedish precision medicine firm Beactica Therapeutics has launched IND-enabling studies for BEA-17, a first-in-class oral degrader targeting LSD1 and CoREST to treat glioblastoma. This shift from preclinical research into rigorous safety and manufacturing protocols marks a critical step toward securing regulatory approval for upcoming first-in-human clinical trials.
Under the vaulted ceilings of Budapest’s Museum of Fine Arts, 100 aesthetic medicine professionals gathered on September 14 to mark the official entry of the Korean skin booster REJURAN into the Hungarian market, signaling a strategic push by PharmaResearch to deepen its footprint across the European continent.
The IAB Tech Lab has unveiled AAMP 3.0, a framework designed to automate the gap between media RFPs and final buy commitments. By introducing the OpenProposal specification, the organization aims to replace manual, human-centric workflows with machine-readable protocols that allow AI agents to negotiate and evaluate ad inventory.
The IAB Tech Lab has introduced AAMP 3.0, a new framework designed to standardize the transition from advertising requests for proposals (RFPs) to finalized media buys. By replacing manual negotiations with machine-readable protocols, the update aims to integrate AI agents directly into the digital advertising planning and transaction lifecycle.
Rock Tech Lithium has signed agreements with Siemens Canada to integrate advanced German digital engineering into its Red Rock Converter project in Ontario. This move marks a shift toward virtual plant modeling, aiming to optimize energy flows and material output before construction of the lithium facility begins.
The European Commission has authorized the use of Rinvoq for children aged two and older suffering from active polyarticular juvenile idiopathic arthritis. This approval introduces a new weight-based oral solution for patients who have failed to respond to standard disease-modifying anti-rheumatic drugs, marking a significant expansion for the medication.
